• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Advocacy
      • Fundamental Rights of People with ALS/MND and Caregivers
      • Advocacy Toolkit
      • Understanding ALS/MND Research
      • Drug Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
      • Expanded Access
    • Care Services
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Drugs in Clinical Trial
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
    • Approved Drugs
      • Riluzole/Tiglutik
      • Radicava/Edaravone
      • Neudexta
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • About
    • Who We Are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
  • Members
    • Member Registration
    • Forgot Password

Sitemap

Pages:

  • Donate
  • Register
    • Edit Your Profile
    • Update Billing Card
    • Welcome
    • Your Membership
  • About the Alliance
    • Who we are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Meetings
      • Newsletters
    • Awards
      • Humanitarian Award Nomination
      • Allied Health Professional Award Nomination
      • Forbes Norris Award Nomination
  • Contact Us
  • Disclaimer
  • Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • Find ALS/MND associations around the world
  • International Alliance of ALS/MND Associations
  • Join the Alliance
    • Member Registration
  • Make a donation
  • Newsletter subscription
  • Privacy notice & Cookies
  • Sitemap
  • Support for PALS & CALS
    • Advocacy
      • Fundamental Rights of People with ALS/MND and Caregivers
      • Advocacy Toolkit
      • Understanding ALS/MND Research
      • Drug Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
      • Expanded Access
    • Care Services
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Approved Drugs
      • Neudexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
    • Drugs in Clinical Trial
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
  • What is ALS/MND?
  • Board Nomination
  • March of Faces
  • Member Webinars
  • Alliance Meeting
  • Submit an Event
  • Submit a Resource
  • Alliance Support Grant
  • Become A Mentor
  • Become A Mentee

Recent Posts:

    Primary Sidebar

    • 20200117_214643

      20200117_214643

    • Mike Rannie, ALS Canada, Diagnosed 2017, Canada

      Mike Rannie, ALS Canada, Diagnosed 2017, Canada

    • Joanne Pratt, Diagnosed 2011 - MND Australia

      Joanne Pratt, Diagnosed 2011 – MND Australia

    • Frank "Papa" Taylor

      Frank “Papa” Taylor

    • Charlie “Hark” Dourney, Diagnosed 2007 - Hark ALS, USA

      Charlie “Hark” Dourney, Diagnosed 2007 – Hark ALS, USA

    • David-Bishop-copy-2

      David-Bishop-copy-2

    • Maurice LeClerc, ALS Canada

      Maurice LeClerc, ALS Canada

    • Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

      Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

    • Elkin-Ramiro-Gaviria-Muñoz-diagnosed-Dec-2018-v3

      Elkin-Ramiro-Gaviria-Muñoz-diagnosed-Dec-2018-v3

    • Rolf Mauch, Association ALS Switzerland, Diagnosed 2015, Switzerland

      Rolf Mauch, Association ALS Switzerland, Diagnosed 2015, Switzerland

    • IMG_3993

      IMG_3993

    • Steven Spencer, Diagnosed 2014 - MND New Zealand

      Steven Spencer, Diagnosed 2014 – MND New Zealand

    • Danny Reviers, Diagnosed 1979 - ALS Liga België, Belgium

      Danny Reviers, Diagnosed 1979 – ALS Liga België, Belgium

    • Antonio Ventriglia, ALS Liga Belgium, Diagnosed 2013, Belgium

      Antonio Ventriglia, ALS Liga Belgium, Diagnosed 2013, Belgium

    • Liong Ting Ngu, MND Malaysia, Diagnosed 2014, Malaysia

      Liong Ting Ngu, MND Malaysia, Diagnosed 2014, Malaysia

    • Angie Bordaen, Diagnosed 2014 - ALS Liga België, Belgium

      Angie Bordaen, Diagnosed 2014 – ALS Liga België, Belgium

    • Denis Blais, Diagnosed 2015 - ALS Canada

      Denis Blais, Diagnosed 2015 – ALS Canada

    • final3878

      final3878

    • David Watson, MND Scotland, Diagnosed 2018, Scotland

      David Watson, MND Scotland, Diagnosed 2018, Scotland

    • Inta Grubb, Diagnosed 2014 - MND Australia

      Inta Grubb, Diagnosed 2014 – MND Australia

    • Valdomiro-Xavier-Honorio-ABrELA

      Valdomiro-Xavier-Honorio-ABrELA

    • 9B63A612-09B4-453E-8430-B76DB0AB5196

      9B63A612-09B4-453E-8430-B76DB0AB5196

    • Richard Clark, MND New Zealand, Diagnosed 2011, New Zealand

      Richard Clark, MND New Zealand, Diagnosed 2011, New Zealand

    • Conny van der Meijden, Diagnosed 2001 - ALS Netherlands

      Conny van der Meijden, Diagnosed 2001 – ALS Netherlands

    • jspic

      jspic

    • Joyce Rusinak, Forbes Norris ALS Center, USA

      Joyce Rusinak, Forbes Norris ALS Center, USA

    • Philip Brindle, MND Association, Diagnosed 2015, England

      Philip Brindle, MND Association, Diagnosed 2015, England

    • Karl Hughes, Diagnosed 2010 - IMNDA, Ireland

      Karl Hughes, Diagnosed 2010 – IMNDA, Ireland

    • Monica Soriano, Diagnosed 2011 - Asociación ELA Argentina

      Monica Soriano, Diagnosed 2011 – Asociación ELA Argentina

    • Jo-and-her-dog-2

      Jo-and-her-dog-2

    • Ian Roberts

      Ian Roberts

    • MND-Robbie-Caliste

      MND-Robbie-Caliste

    • Fabio-Correia-2

      Fabio-Correia-2

    • Len Johnrose, MND Association, Diagnosed 2017, England

      Len Johnrose, MND Association, Diagnosed 2017, England

    • Orlando Ruiz, Diagnosed 2001 - ACELA, Colombia

      Orlando Ruiz, Diagnosed 2001 – ACELA, Colombia

    • Eddy LeFrançois, Diagnosed 1992 - ALS Canada

      Eddy LeFrançois, Diagnosed 1992 – ALS Canada

    • Norm MacIsaac, ALS Society of Canada, ALS Society of Quebec, Diagnosed 2014, Canada

      Norm MacIsaac, ALS Society of Canada, ALS Society of Quebec, Diagnosed 2014, Canada

    • Francisco Perez Palop, Diagnosed 2013 - FUNDELA, Spain

      Francisco Perez Palop, Diagnosed 2013 – FUNDELA, Spain

    • Lachlan Terry, MND Australia, Diagnosed 2015, Australia

      Lachlan Terry, MND Australia, Diagnosed 2015, Australia

    • Duncan Bayly - MND Australia

      Duncan Bayly – MND Australia

    • Chris McCauley, Diagnosed 2015 - ALS Canada

      Chris McCauley, Diagnosed 2015 – ALS Canada

    • Josée Kolijn-de Man, Diagnosed 2015 - ALS Patients Connected, The Netherlands

      Josée Kolijn-de Man, Diagnosed 2015 – ALS Patients Connected, The Netherlands

    • Brian Lovell, Diagnosed 2011 - MND Australia

      Brian Lovell, Diagnosed 2011 – MND Australia

    • Carlos Gomez Matallanas, Diagnosed 2014 - FUNDELA, Spain

      Carlos Gomez Matallanas, Diagnosed 2014 – FUNDELA, Spain

    • MoF-Christian-Bär

      MoF-Christian-Bär

    • Willi-Klein

      Willi-Klein

    • Joy Blakeley, Diagnosed 2017 - MND Australia

      Joy Blakeley, Diagnosed 2017 – MND Australia

    • Mary Thomas, Diagnosed 2013 - MND Australia

      Mary Thomas, Diagnosed 2013 – MND Australia

    • Erwin Coppejans, Diagnosed 2007 - ALS Liga België, Belgium

      Erwin Coppejans, Diagnosed 2007 – ALS Liga België, Belgium

    • Oliver Juenke, DGM, Germany

      Oliver Juenke, DGM, Germany

    Learn more about the March of Faces

    Subscribe to our Bi-Monthly Newsletter

    Fill out the form below to subscribe to the Alliance’s bi-monthly newsletter, packed with updates from members associations from around the world!

    Footer

    Keep in touch

    Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

    "*" indicates required fields

     
    This field is for validation purposes and should be left unchanged.

    • Email
    • Facebook
    • Instagram
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2022 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login